Pharmacological characterization of losartan as a CCR2 antagonist and pre-clinical and pharmacodynamic assessment as a potential anti-metastatic therapy

Files

Regan, Daniel P., author

Dow, Steven, advisor

Schenkel, Alan, committee member

Thamm, Douglas, committee member

Slansky, Jill, committee member

Basaraba, Randall, committee member

To view the abstract, please see the full text of the document.

CCL2

dogs

monocytes

CCR2

cancer

metastasis